Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for amphotericin root_notes_note in Note (approximate match)

Showing 531 - 540 of 2111 results

First page
Previous page
Next page
Next page

(3R)-4-((4-CHLOROPHENYL)METHYL)-7-FLUORO-1,2,3,4-TETRAHYDRO-5-(METHYLSULFONYL)-1-OXOCYCLOPENT(B)INDOLE-3-ACETIC ACID

LI7K2MH2IJ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM

02X1GF8X88

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

11-(1-PIPERAZINYL)DIBENZO(B,F)(1,4)THIAZEPINE 5-OXIDE

BIJ1Q409UA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

3-AZANYL-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE

S8GR9YM9MV

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Muscarinic acetylcholine receptor M4

Conditions:

VU 10010 is a selective allosteric potentiator of M4 acetylcholine receptors. VU 10010 had no agonist, antagonist or allosteric potentiator activity at P2Y1R or mGluR5. VU 10010 is selective for M4 relative to other mAChRs - this compound does not displace [3H]NMS binding at any (rM1, rM2, rM3 and rM5) mAChR subtype. VU10010 was not found to be centrally active. It suffers from poor physiochemical properties. Novel analogs of VU10010 are CNS penetrant following systemic administration.

(5-ETHYLSULFONYL-2-(OXAN-4-YL)-3,4-DIHYDRO-1H-PYRIDO(4,3-B)INDOL-8-YL)-(4-METHYLPIPERIDIN-1-YL)METHANONE

4L8EG56VDA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

7,9,12-Trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one

Y4NP4FY8AD

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Methyl 3-[4-[(2-ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridin-1-yl)methyl]phenyl]-2-propenoate

V332CR4PML

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

1-BENZO(B)THIEN-2-YLCYCLOHEXANAMINE

4JCE4LAL96

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

6,7,8,9-Tetrahydro-7-methyl-5H-dibenz[b,i][1,6]oxazecine

3J8UBM9KES

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

1-(Phenylmethyl)pyrrolo(3,2-b)pyridine

YDR3S52RQL

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of (3R)-4-((4-CHLOROPHENYL)METHYL)-7-FLUORO-1,2,3,4-TETRAHYDRO-5-(METHYLSULFONYL)-1-OXOCYCLOPENT(B)INDOLE-3-ACETIC ACID

ABSOLUTE

(3R)-4-((4-CHLOROPHENYL)METHYL)-7-FLUORO-1,2,3,4-TETRAHYDRO-5-(METHYLSULFONYL)-1-OXOCYCLOPENT(B)INDOLE-3-ACETIC ACID

Structure of 7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM

ABSOLUTE

7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM

Structure of 11-(1-PIPERAZINYL)DIBENZO(B,F)(1,4)THIAZEPINE 5-OXIDE

RACEMIC

11-(1-PIPERAZINYL)DIBENZO(B,F)(1,4)THIAZEPINE 5-OXIDE

Structure of 3-AZANYL-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE

ACHIRAL

3-AZANYL-N-((4-CHLOROPHENYL)METHYL)-4,6-DIMETHYL-THIENO(2,3-B)PYRIDINE-2-CARBOXAMIDE

Structure of (5-ETHYLSULFONYL-2-(OXAN-4-YL)-3,4-DIHYDRO-1H-PYRIDO(4,3-B)INDOL-8-YL)-(4-METHYLPIPERIDIN-1-YL)METHANONE

ACHIRAL

(5-ETHYLSULFONYL-2-(OXAN-4-YL)-3,4-DIHYDRO-1H-PYRIDO(4,3-B)INDOL-8-YL)-(4-METHYLPIPERIDIN-1-YL)METHANONE

Structure of 7,9,12-Trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one

ACHIRAL

7,9,12-Trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one

Structure of Methyl 3-[4-[(2-ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridin-1-yl)methyl]phenyl]-2-propenoate

ACHIRAL

Methyl 3-[4-[(2-ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridin-1-yl)methyl]phenyl]-2-propenoate

Structure of 1-BENZO(B)THIEN-2-YLCYCLOHEXANAMINE

ACHIRAL

1-BENZO(B)THIEN-2-YLCYCLOHEXANAMINE

Structure of 6,7,8,9-Tetrahydro-7-methyl-5H-dibenz[b,i][1,6]oxazecine

ACHIRAL

6,7,8,9-Tetrahydro-7-methyl-5H-dibenz[b,i][1,6]oxazecine

Structure of 1-(Phenylmethyl)pyrrolo(3,2-b)pyridine

ACHIRAL

1-(Phenylmethyl)pyrrolo(3,2-b)pyridine

Showing 531 - 540 of 2111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1